Skip to content

Released May 10, 2016, after the close

10-Q filed May 10, 2016, 40 days after period end · 0001104659-16-119768

Q1 2016 · 10-Q
Revenue$66.04M+128.3% vs Q1 2015+23.9% vs Q4 2015
Net Income-$13.30Mno prior Q1 2015 on fileno prior Q4 2015 on file
EPS Diluted-$0.09N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$1,968,000N/M
Operating Cash Flow$161,000N/M
Free Cash Flowderived-$847,000N/M
Margins · derived
Operating margin-3.0%+94.0 pt vs Q1 2015
Net margin-20.1%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2016Q1 2015Q1 2014Q1 2013
Revenue$66.04M$28.93M$14.61M$3.26M
Net Income-$13.30M———
EPS Diluted-$0.09-$0.24-$0.38-$0.87

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR